Peripheral neuropathies are a group of acquired and hereditary disorders presenting with different distribution and nerve fiber class involvement. The overall prevalence is 2.4%, increasing to 8% in the elderly population. However, the frequency may vary depending on the underlying pathogenesis and association with systemic diseases. Distal symmetric polyneuropathy is the most common form, though multiple mononeuropathies, non-length dependent neuropathy and small fiber neuropathy can occur and may require specific diagnostic tools. The use of uniform outcome measures in peripheral neuropathies is important to improve the quality of randomized controlled trials, enabling comparison between studies. Recent developments in defining the optimal set of outcome measures in inflammatory neuropathies may serve as an example for other conditions. Diagnostic and outcome measure advances in peripheral neuropathies will be discussed.

Advances in diagnostics and outcome measures in peripheral neuropathies / I.S.J. Merkies, C.G. Faber, G. LAURIA PINTER. - In: NEUROSCIENCE LETTERS. - ISSN 0304-3940. - 596(2015 Jun 02), pp. 3-13. [10.1016/j.neulet.2015.02.038]

Advances in diagnostics and outcome measures in peripheral neuropathies

G. LAURIA PINTER
2015

Abstract

Peripheral neuropathies are a group of acquired and hereditary disorders presenting with different distribution and nerve fiber class involvement. The overall prevalence is 2.4%, increasing to 8% in the elderly population. However, the frequency may vary depending on the underlying pathogenesis and association with systemic diseases. Distal symmetric polyneuropathy is the most common form, though multiple mononeuropathies, non-length dependent neuropathy and small fiber neuropathy can occur and may require specific diagnostic tools. The use of uniform outcome measures in peripheral neuropathies is important to improve the quality of randomized controlled trials, enabling comparison between studies. Recent developments in defining the optimal set of outcome measures in inflammatory neuropathies may serve as an example for other conditions. Diagnostic and outcome measure advances in peripheral neuropathies will be discussed.
neuropathy; sodium channel genes; outcome measures; skin biopsy; quantitative sensory testing; confocal corneal microscopy; evoked potential; imaging; ultrasounds; cardiac scintigraphy
Settore MED/26 - Neurologia
2-giu-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
Adv Diagn Neurop_NSL2015.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 213.18 kB
Formato Adobe PDF
213.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/529215
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 13
social impact